Permanent Forum on International Pharmaceutical Crime: Protecting public health globally

The Permanent Forum on International Pharmaceutical Crime (PFIPC) is an international enforcement forum aimed at protecting public health through the exchange of information and ideas to foster mutual cooperation.

Learn More

Our Mission

Our mission is to foster international cooperation in the fight against pharmaceutical crime. We strive to protect public health by sharing knowledge, resources, and best practices among enforcement agencies worldwide.

Learn more about our initiatives, the work we do, and how we are making a difference globally. Stay informed about our latest efforts to combat counterfeit and illegal pharmaceuticals.

Statement on the FDA and HHS enforcement discretion policy for 503a compounding with certain peptides

"Today's decision leaves Americans in a grey area as to whether peptides are safe or not, even though the FDA’s own scientists recommended against voting in favor of these substances due to concerns with evidence."

October 26, 2026: PSM files citizen petition asking FDA not to allow compounding of peptides

The peptides in question are untested and poorly defined, and making them easier to compound is a threat to public safety.

Case overview: Eli Lilly and Co v InstantRx, et al (2026 — ) – ongoing

Eli Lilly filed a complaint against InstantRx and other defendants that allegedly distributed counterfeit and/or misbranded versions of Lilly-branded medicines through online pharmacy to pharmacy marketplaces.

October 19, 2026: Two deaths linked to bootlegged retatrutide

Two deaths have been linked to black market versions of retatrutide, as a British woman warns followers that taking an early dose of the drug “nearly killed” her.

Get Involved

Join us in our mission to protect public health. Learn more about how you can contribute to our efforts or collaborate with us. Your support and involvement are crucial to our success.